Could Stem Cells Help End the Pandemic?
MARCH 5, 2021
- Stem cell therapies have advanced in recent years, particularly in the field of regenerative medicine.
- The COVID-19 pandemic triggered a race for biotechnology and pharmaceutical companies seeking applications for both treatments and a cure.
- Stem cell therapy has been proposed as a potential treatment for COVID-19 patients with severe symptoms.
- While COVID-19 vaccine/treatment stocks have been popular, investors should remain mindful of relevant ESG risks associated with proposed stem cell applications.